Cargando…

Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of some chemotherapy regimens. Lithium has been suggested for CIPN in some animal studies. We aimed to study lithium’s preventive effect on CIPN in breast cancer patients treated with taxanes and platinum-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najafi, S., Heidarali, Z., Rajabi, M., Omidi, Z., Zayeri, F., Salehi, M., Haghighat, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611897/ https://www.ncbi.nlm.nih.gov/pubmed/34819131 http://dx.doi.org/10.1186/s13063-021-05800-w

Ejemplares similares

The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial)
por: Joy, Lodewijckx, et al.
Publicado: (2022)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
por: Komatsu, Hiroko, et al.
Publicado: (2019)

Chemotherapy-induced peripheral neuropathy. Part II. Prevention
por: Brzeziński, Krzysztof
Publicado: (2012)

Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial
por: Salehi, Zeinab, et al.
Publicado: (2015)

Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy
por: Kawata, Daisuke, et al.
Publicado: (2017)

Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
por: Hincker, Alexander, et al.
Publicado: (2019)

Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)

Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
por: Ben-Horin, Idan, et al.
Publicado: (2017)

Oncology nurses’ knowledge, practice, and confidence toward chemotherapy-induced peripheral neuropathy in Jordan
por: Al-Atiyyat, Nijmeh M., et al.
Publicado: (2018)

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
por: Rodwin, Rozalyn L., et al.
Publicado: (2022)

A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy
por: Song, Si-Yeon, et al.
Publicado: (2020)

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)

Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019)

Acupuncture for diabetic peripheral neuropathy: study protocol for a randomized, placebo-controlled trial
por: Deng, Haiping, et al.
Publicado: (2020)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
por: Schloss, Janet, et al.
Publicado: (2016)

Prevention and Treatment for Chemotherapy-Induced Peripheral  Neuropathy: Therapies Based on CIPN Mechanisms
por: Hu, Lang-Yue, et al.
Publicado: (2019)

Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
por: Chen, Jie, et al.
Publicado: (2021)

ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy
por: Vitale, Maria Giuseppa, et al.
Publicado: (2020)

A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial)
por: Kang, Young-Joon, et al.
Publicado: (2023)

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy
por: Kotaka, Masahito, et al.
Publicado: (2020)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
por: Malacrida, Alessio, et al.
Publicado: (2019)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
por: Tsai, Chih-Hung, et al.
Publicado: (2021)

Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis
por: Knoerl, Robert, et al.
Publicado: (2022)

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997)

Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial
por: Bakry, Hala M., et al.
Publicado: (2023)

Acupuncture May Help to Prevent Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Sham-Controlled, Single-Blind Study
por: Huang, Ming-Cheng, et al.
Publicado: (2023)

Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
por: Li, Yang, et al.
Publicado: (2021)

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)
por: Pfeiffer, Per, et al.
Publicado: (2022)

The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review
por: Sphar, Bethany G., et al.
Publicado: (2020)

Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial
por: Bakhshayeshi, S., et al.
Publicado: (2011)

Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial
por: Huang, Chien-Chen, et al.
Publicado: (2021)

Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors
por: McNeish, Brendan L., et al.
Publicado: (2021)

Morning Chronotype Decreases the Risk of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer
por: Son, Kyung-Lak, et al.
Publicado: (2022)

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial
por: Bao, Ting, et al.
Publicado: (2020)

Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials
por: Wang, Chenkun, et al.
Publicado: (2022)

A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
por: Lopez, Gabriel, et al.
Publicado: (2022)

Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial
por: Najafi, Safa, et al.
Publicado: (2023)

Challenges in the Conduct of Research: Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7pmsepdt2rur1cljgohjipdhc3